BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23445217)

  • 1. Considerations for the development of health-based surface dust cleanup criteria for beryllium.
    Shay E; De Gandiaga E; Madl AK
    Crit Rev Toxicol; 2013 Mar; 43(3):220-43. PubMed ID: 23445217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a health risk-based surface contamination cleanup standard for occupational exposure to beryllium.
    Damian P
    Toxicol Mech Methods; 2011 Feb; 21(2):97-102. PubMed ID: 20649413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety criteria in working with metallic beryllium].
    Petrin SV; Petrina LS; Pinaev VS
    Gig Sanit; 2004; (2):28-31. PubMed ID: 15141624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vacuum sampling techniques for industrial hygienists, with emphasis on beryllium dust sampling.
    Creek KL; Whitney G; Ashley K
    J Environ Monit; 2006 Jun; 8(6):612-8. PubMed ID: 16767227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure pathway assessment at a copper-beryllium alloy facility.
    Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
    Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
    Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
    Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
    Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
    Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.
    Stefaniak AB; Hoover MD; Day GA; Dickerson RM; Peterson EJ; Kent MS; Schuler CR; Breysse PN; Scripsick RC
    J Environ Monit; 2004 Jun; 6(6):523-32. PubMed ID: 15173904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beryllium: a modern industrial hazard.
    Kreiss K; Day GA; Schuler CR
    Annu Rev Public Health; 2007; 28():259-77. PubMed ID: 17094767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of a program to prevent beryllium disease.
    Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
    Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
    Johnson JS; Foote K; McClean M; Cogbill G
    Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational Exposure to Beryllium. Final rule.
    Occupational Safety and Health Administration (OSHA), Department of Labor
    Fed Regist; 2017 Jan; 82(5):2470-757. PubMed ID: 28071878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of beryllium sensitization and chronic beryllium disease.
    Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
    J Occup Environ Hyg; 2006 Apr; 3(4):D42-3. PubMed ID: 16507518
    [No Abstract]   [Full Text] [Related]  

  • 18. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
    Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.
    Stefaniak AB; Chipera SJ; Day GA; Sabey P; Dickerson RM; Sbarra DC; Duling MG; Lawrence RB; Stanton ML; Scripsick RC
    J Toxicol Environ Health A; 2008; 71(22):1468-81. PubMed ID: 18836922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of occupational health for adverse health effects of beryllium and its compounds in workplaces - Recent trends and issues in Japan].
    Toyooka T; Koda S
    Sangyo Eiseigaku Zasshi; 2021 Mar; 63(2):31-42. PubMed ID: 32788509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.